Pelage Pharmaceuticals
Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing novel treatments for hair loss. Their lead program, PP405, is a topical small molecule designed to reactivate dormant hair follicle stem cells and restart hair growth. This approach offers a potential solution for androgenetic alopecia and other forms of hair loss.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $16.75M
Date: 27-Feb-2024
Investors: GV, Main Street Advisors, Visionary Ventures, YK BioVentures
Markets: Regenerative Medicine, Biotechnology, Healthtech, Dermatology, Hair Follicle Regeneration, Therapeutic Innovation, Clinical Trials, Androgenetic Alopecia, Telogen Effluvium, Chemotherapy-induced Hair Loss, Anti-aging
HQ: Los Angeles, California, United States
Founded: 2018
Website: https://pelagepharma.com/
LinkedIn: https://www.linkedin.com/company/pelage-pharmaceuticals
Crunchbase: https://www.crunchbase.com/organization/pelage-pharma
Leave a Comment
Comments
No comments yet.